PER 2.50% 8.2¢ percheron therapeutics limited

UPDATE ON PFIZER’S PHASE 1B OPEN-LABEL MINI-DYSTROPHIN GENE THERAPY TRIAL FOR DUCHENNE, page-78

  1. 13,236 Posts.
    lightbulb Created with Sketch. 1404
    There You go again Akki:
    of course it was a “Woe “ for Sarepta
    Leaked: that’s why Sarepta’s share price dropped when they made a positive announcement the other day re DMD….
    Sarepta was depending on good news soon fron
    Lysogene……Could be that they see a better result investing in Anp
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.2¢
Change
0.002(2.50%)
Mkt cap ! $73.92M
Open High Low Value Volume
8.0¢ 8.2¢ 7.9¢ $16.80K 210.0K

Buyers (Bids)

No. Vol. Price($)
1 24999 7.9¢
 

Sellers (Offers)

Price($) Vol. No.
8.3¢ 31992 1
View Market Depth
Last trade - 16.10pm 06/09/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.